Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Increased CD127+ and decreased CD57+ T cell expression levels in HIV-infected patients on NRTI-sparing regimens

Fig. 3

In vitro assays in CD4+ T and CD8+ T cells in the presence of HIV. a–f In vitro assays confirmed that the deleterious effect of a NRTIs-containing regimen was due to NRTIs, especially the combination tenofovir plus emtricitabine (TRU, Truvada); KVX, Kivexa (combination of Lamivudine plus Abacavir); DRV, Darunavir; MVC, Maraviroc; CONTROL, No drugs; *variables with a p value of < 0.05 were considered statistically significant

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us